AMD Treatment Delay for 20 Percent Hong Kong Seniors During the Pandemic; Eyesight Worsened in 35 Percent of Patients

(L-R): Dr. Lee Ka-yau, ophthalmologist; Mr. Tsang Kin-ping, president of Retina Hong Kong; Mr. Choi, patient representative, at the press conference on June 28, 2022. Adrian Yu/The Epoch Times

Age-related macular degeneration (AMD or ARMD), a common eye disease in the elderly, is categorized into DRY and WET. Wet macular degeneration or Neovascular AMD can also be the culprit of vision loss.

A patient organization survey found that, follow-up diagnosis of nearly 20 percent of patients with wet elderly macular degeneration, were on average,  delayed by up to two months due to the fifth wave of the pandemic.